DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 2, 1996, Pages 83-87

  Cormican, M G ^a   Hollis, R J ^a   Pfaller, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DNA; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA GLABRATA; CLINICAL ARTICLE; DNA DETERMINATION; DNA RESTRICTION; FUNGUS IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATION PROCEDURE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0030174942     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00083-1     Document Type: Article

References (23)

1. Aisner J, Schimpf SC, Sutherland JC, Young M, Wiernik PH (1976) Torulopsis glabrata infections in patients with cancer. Am J Med 61:23-28.
2. Beck-Sague CM, Jarvis WR (1993) National Nosocomial Infection Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980-1990. J Infect Dis 167:1247-1251.
3. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD (1994) Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 32:452-156.
4. Doebbeling BN, Lehmann PF, Hollis RJ, Wu LC, Widmer AF, Voss A, Pfaller MA (1993) Comparison of pulsed field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 16: 377-383.
5. Espinel-Ingroff A, Kish CW Jr, Kerkering TM, Fromtling RA, Bartizal K, Galgiani JN, Villareal K, Pfaller MA, Gerarden T, Rinaldi MG, Fothergill A (1992) Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 30: 3138-3145.
6. Kwon Chung KJ, Bennett JE (1992) Candidiasis. In Medical Mycology, Kwon Chung KJ, Bennett JE, Lea and Febiger: Pennsylvania, PA, pp. 280-336.
7. National Committee for Clinical Laboratory Standards (1995) Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, PA.
8. Pfaller MA (1992) Epidemiologic typing methods for mycoses. Clin Infect Dis 14(Suppl 1):S4-S10.
9. Pfaller MA (1995) Epidemiology of candidiasis. J Hosp Infect 30(Suppl):329-338.
10. Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG, Cooper CR, McGinnis MR (1995) Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J Clin Microbiol 33:1104-1107.
11. Pfaller MA, Barry AL (1995) In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopathologia 130: 3-9.
12. Pfaller MA, Houston A, Coffmann S (1996) Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 34:58-61.
13. Price MF, LaRocco MT, Gentry LO (1994) Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a five year period. Antimicrob Agents Chemother 326:845-851.
14. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD (1995) Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrob Agents Chemother 39:40-44.
15. Rubinstein E, Lang R (1995) Fungal endocarditis. Eur Heart J 16(Suppl B):84-89.
16. Sewell D, Pfaller MA, Barry AL (1994) Comparison of broth macrodilution, broth microdilution, and Etest antifungal susceptibility tests. J Clin Microbiol 30:3138-3145.
17. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G (1995) Torulopsis glabrata vaginitis. Obstetr Gynecol 85: 993-998.
18. Sullivan D, Bennett D, Henman M, et al. (1993) Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol 31:2124-2133.
19. Vazquez JA, Beckley A, Donabedian S, Sobel JD, Zervos MJ (1993) Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans. J Clin Microbiol 31:2021-2030.
20. Warnock DW, Burke J, Cope NJ, Johnson EM, von Fraunhofer NA, Williams EW (1988) Fluconazole resistance in T. glabrata. Lancet (ii):1310.
21. Warren NG, Hazen KC (1995) Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH. American Society of Microbiology, Washington DC, pp. 723-737.
22. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R (1993) Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropaenic bone marrow transplant patients. Antimicrob Agents Chemother 37:1847-1849.
23. Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115-125.